[go: up one dir, main page]

IL138624A0 - Nucleic acid transfer vectors, compositions containing same and uses - Google Patents

Nucleic acid transfer vectors, compositions containing same and uses

Info

Publication number
IL138624A0
IL138624A0 IL13862499A IL13862499A IL138624A0 IL 138624 A0 IL138624 A0 IL 138624A0 IL 13862499 A IL13862499 A IL 13862499A IL 13862499 A IL13862499 A IL 13862499A IL 138624 A0 IL138624 A0 IL 138624A0
Authority
IL
Israel
Prior art keywords
nucleic acid
compositions containing
transfer vectors
containing same
acid transfer
Prior art date
Application number
IL13862499A
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9803573A external-priority patent/FR2776669B1/en
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL138624A0 publication Critical patent/IL138624A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/15Nucleic acids forming more than 2 strands, e.g. TFOs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13862499A 1998-03-24 1999-03-19 Nucleic acid transfer vectors, compositions containing same and uses IL138624A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9803573A FR2776669B1 (en) 1998-03-24 1998-03-24 NUCLEIC ACID TRANSFER VECTORS, COMPOSITIONS CONTAINING SAME, AND USES THEREOF
US8584898P 1998-05-18 1998-05-18
PCT/FR1999/000643 WO1999049067A1 (en) 1998-03-24 1999-03-19 Nucleic acid transfer vectors, compositions containing same and uses

Publications (1)

Publication Number Publication Date
IL138624A0 true IL138624A0 (en) 2001-10-31

Family

ID=26234216

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13862499A IL138624A0 (en) 1998-03-24 1999-03-19 Nucleic acid transfer vectors, compositions containing same and uses

Country Status (12)

Country Link
EP (1) EP1066396A1 (en)
JP (1) JP2002507429A (en)
KR (1) KR20010074456A (en)
CN (1) CN1292827A (en)
AU (1) AU758406B2 (en)
BR (1) BR9909044A (en)
CA (1) CA2323831A1 (en)
HU (1) HUP0102413A3 (en)
IL (1) IL138624A0 (en)
NO (1) NO20004648L (en)
PL (1) PL342944A1 (en)
WO (1) WO1999049067A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ522860A (en) 2000-05-26 2004-09-24 Gencell S Purification of a triple helix formation with an immobilized oligonucleotide
FR2871465B1 (en) * 2004-06-15 2006-09-08 Centre Nat Rech Scient Cnrse COLLECTIONS OF TRACEABLE COMPOUNDS AND USES THEREOF
US7943589B2 (en) 2005-06-03 2011-05-17 President And Fellows Of Harvard College siRNA microbicides for preventing and treating diseases
US7795380B2 (en) 2006-06-02 2010-09-14 University Of Iowa Research Foundation Compositions and methods for nucleic acid delivery
WO2017156038A2 (en) * 2016-03-07 2017-09-14 Alere San Diego, Inc. Immunoassay controls and the use thereof
RU2731513C2 (en) * 2018-12-21 2020-09-03 Селл энд Джин Терапи Лтд Gene-therapeutic dna-vector based on gene-therapeutic dna-vector vtvaf17, carrying target gene selected from group of genes nos2, nos3, vip, kcnma1, cgrp, to increase expression level of these target genes, method for production and use thereof, strain escherichia coli scs110-af/vtvaf17-nos2, or escherichia coli scs110-af/vtvaf17-nos3, or escherichia coli scs110-af/vtvaf17-vip, or escherichia coli scs110-af/vtvaf17-kcnma1, or escherichia coli scs110-af/vtvaf17-cgrp, carrying gene-therapeutic dna vector, method for production thereof, method for industrial production of gene-therapeutic dna vector
WO2024206118A1 (en) * 2023-03-24 2024-10-03 Yarrow Therapeutics, Inc. Nuclear localization polypeptides and conjugates and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2028792A (en) * 1991-05-17 1992-12-30 Uab Research Foundation Sequence specific dna binding drugs
US5670347A (en) * 1994-05-11 1997-09-23 Amba Biosciences Llc Peptide-mediated gene transfer
FR2731014B1 (en) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa DNA MOLECULES, PREPARATION AND USE IN GENE THERAPY

Also Published As

Publication number Publication date
PL342944A1 (en) 2001-07-16
CA2323831A1 (en) 1999-09-30
HUP0102413A1 (en) 2001-10-28
CN1292827A (en) 2001-04-25
AU758406B2 (en) 2003-03-20
WO1999049067A1 (en) 1999-09-30
EP1066396A1 (en) 2001-01-10
BR9909044A (en) 2000-12-05
HUP0102413A3 (en) 2003-09-29
JP2002507429A (en) 2002-03-12
KR20010074456A (en) 2001-08-04
NO20004648D0 (en) 2000-09-18
AU3406200A (en) 2000-12-14
NO20004648L (en) 2000-09-18

Similar Documents

Publication Publication Date Title
PL342081A1 (en) Novel quaternary ammonia compounds, compositions containing them and their application
GB2361904B (en) Transfer system
AU4289399A (en) Nucleic acid transfer phage
IL162274A (en) Nucleic acid and protein designated 193p1e1b and compositions containing the same
PL339920A1 (en) Synergetic compositions comprising oxathiazine and benzothiophene-2-carboxamido-s,s-dioxide
IL130608A0 (en) Novel nucleic and amino acid sequence
IL138624A0 (en) Nucleic acid transfer vectors, compositions containing same and uses
IL148805A0 (en) Gene transfer vectors
GB9717932D0 (en) Estimation of nucleic acid
HUP0200345A3 (en) Novel nucleic acid transferring agents, compositions containing them and uses
HUP0102455A3 (en) Novel nucleic acid transfer agents, compositions containing same and uses
GB9817909D0 (en) DNA constructs
AU1728197A (en) Lipopolyamine compound, pharmaceutical composition and nucleic acid transfer vector containing same, and preparation method
GB9917875D0 (en) Nucleic acid constructs
ZA992262B (en) Vectors for transferring nucleic acids, compositions containing them and their uses.
AU4513599A (en) Nucleotide sequence
HUP0003585A3 (en) Gene coding for androctonine, vector containing same and transformed disease-resistant plants obtained
AU7790300A (en) Cd29 pig protein, nucleic acid coding for said protein and the applications thereof
EP1067140A4 (en) Novel hemolytic active proteins and genes encoding the same
GB9822490D0 (en) Nucleic acid
GB9823481D0 (en) Nucleic acid
IL142278A0 (en) Imidazo-isoquinoline compounds, their compositions and uses
AUPP704498A0 (en) Nucleic acid sequence
HUP0101911A3 (en) Novel sequence class of genes, corresponding proteins and the use of the same
GB9701886D0 (en) Nucleic acid